Global Pricing and Reimbursement
We are experienced at building user friendly forecasting models to optimize pricing and demand scenarios and ultimately understand the effects of differential payer pricing (e.g., government vs commercial contracts, including value based contracting) on ASP, AMP, and gross-to-net revenue.
Case Study
Situation: A client was interested in launching a therapeutic in both a rare neurodegenerative and a common psychiatric indication and wanted to understand whether to launch product as a dual brand dual price or under a single brand/dual indication and if launching as a single brand, understand how to optimize pricing to ensure payer coverage for both indications.
Approach: Patient advocates, clinicians, and payers from the USwere interviewed and shown target product profiles and provided input on patient important outcomes. Payers from EU5 markets were also interviewed to assess value, access, and pricing nuances in these markets. Scenario analysis was used to evaluate the potential effects of different pricing and branding strategies based on input from KOL interviews and launches of analogues.
Outcome: Client was able to understand the pricing complexities regarding launching in multiple indications.
Approach: Patient advocates, clinicians, and payers from the USwere interviewed and shown target product profiles and provided input on patient important outcomes. Payers from EU5 markets were also interviewed to assess value, access, and pricing nuances in these markets. Scenario analysis was used to evaluate the potential effects of different pricing and branding strategies based on input from KOL interviews and launches of analogues.
Outcome: Client was able to understand the pricing complexities regarding launching in multiple indications.